Ankylosing spondylitis
Feature
Certolizumab pegol shows promise for nr-axSpA treatment
C-AXSPAND is the first year-long trial to show positive results vs. placebo in nonradiographic axial spondyloarthritis.
From the Journals
MACE risk similar across arthritis subtypes
The older age of patients with rheumatoid arthritis explained most of their elevated risk of major adverse cardiovascular events.
From the Journals
Reassurance for women taking certolizumab during pregnancy
Exposure to certolizumab pegol does not appear to be associated with an increased risk of fetal death or congenital malformations.
News from the FDA/CDC
TB in 2017: Good news and bad news
Incidence is lower than ever, but elimination is still a long way off.
From the Journals
Axial SpA disease activity remains mostly stable throughout pregnancy
Disease activity, physical functioning seem to be worst later in pregnancy.
News
FDA approves certolizumab label update for pregnancy, breastfeeding
Approval is based on data from the CRIB and CRADLE studies.
Conference Coverage
Maternal biologic therapy does not affect infant vaccine responses
MAUI, HAWAII – Update from national PIANO registry of women with IBD.
Conference Coverage
How to direct refer for GI endoscopy
MAUI, HAWAII – There is a right way and a wrong way to make a direct referral for GI endoscopy, says gastroenterologist Uma Mahadevan, MD.
Conference Coverage
Role of musculoskeletal ultrasound expands in rheumatic diseases
MAUI, HAWAII – Recent studies highlight ultrasound’s utility across a broad spectrum of rheumatic diseases.
Latest News
TNF inhibitors curb spinal x-ray progression in ankylosing spondylitis
MAUI, HAWAII – Benefit is mediated via inhibition of disease activity.
From the Journals
ACR sounds more welcoming tone in new biosimilars position paper
But in a related editorial Dr. Roy Fleischmann notes that there are still many concerns regarding biosimilars.